PharmiWeb.com - Global Pharma News & Resources
13-Aug-2020

Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List

The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.

Innovation is a key to success in business. And it's been an especially important asset during the COVID-19 pandemic, which has challenged companies large and small to find new ways of innovating.

It's a challenge that Johnson & Johnson has taken head on this year, helping it earn a spot for the second year on the 2020 Fast Company Best Workplaces for Innovators list, which recognizes companies from around the world that are encouraging bold experimentation at every level of their organization.

Johnson & Johnson Innovation—comprised of innovation centers and teams across the globe—also made Fast Company's inaugural 2020 Innovative Team of the Year list, which honors groups whose creativity and passion have driven a major breakthrough.

Johnson & Johnson is one of just 10 companies to appear on both lists, which were compiled in collaboration with consulting firm Accenture.

“It’s an honor to be recognized by Fast Company,” says Peter Fasolo, Ph.D.Peter Fasolo, Ph.D.,Executive Vice President, Chief Human Resources Officer, Johnson & Johnson, Executive Vice President, Chief Human Resources Officer, Johnson & Johnson. “At Johnson & Johnson, we work to foster an environment where employees can innovate and experiment, and this year especially has shown us that our agile ways of working and innovating are helping to develop our employees, as well as meet the world’s most urgent health challenges.”

In March, Johnson & Johnson announced a lead vaccine candidate in development at the Janssen Pharmaceutical Companies of Johnson & Johnson and its plans to put it into a Phase 1/2a human clinical trial no later than September 2020—a timeline that, in June, the company announced it had accelerated.

Editor Details

Related Links

Last Updated: 13-Aug-2020